DuChemBIO Co.,Ltd. (KOSDAQ:176750)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,070
-110 (-1.08%)
At close: Aug 28, 2025
-1.08%
Market Cap285.43B
Revenue (ttm)35.81B
Net Income (ttm)7.26B
Shares Out28.34M
EPS (ttm)262.40
PE Ratio38.38
Forward PE18.21
Dividendn/a
Ex-Dividend Daten/a
Volume36,203
Average Volume50,887
Open10,270
Previous Close10,180
Day's Range9,960 - 10,270
52-Week Range7,070 - 19,570
Beta-0.03
RSI43.57
Earnings DateAug 14, 2025

About DuChemBIO

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2002
Employees 115
Stock Exchange KOSDAQ
Ticker Symbol 176750
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.